Effects of Nandrolone on Outcomes and Metabolic Response in Critically Ill Patients

Background: Two major difficulties in critical care are muscle weakness and malnutrition. Their prevalence in critically ill patients is about 30-50% during hospital stays, and they can also affect routine patient life after discharge, even leading to recurrent infection and death. Metabolic respon...

Full description

Bibliographic Details
Main Authors: Hamed Abdollahi, Abolghasem Yousefi, Ladan Ghadami
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2023-06-01
Series:Archives of Anesthesia and Critical Care
Subjects:
Online Access:https://aacc.tums.ac.ir/index.php/aacc/article/view/617
_version_ 1797742513077878784
author Hamed Abdollahi
Abolghasem Yousefi
Ladan Ghadami
author_facet Hamed Abdollahi
Abolghasem Yousefi
Ladan Ghadami
author_sort Hamed Abdollahi
collection DOAJ
description Background: Two major difficulties in critical care are muscle weakness and malnutrition. Their prevalence in critically ill patients is about 30-50% during hospital stays, and they can also affect routine patient life after discharge, even leading to recurrent infection and death. Metabolic responses to injury have specific effects on metabolic phases in patients. Methods: This study is a randomized, double-blind, clinical trial on critically ill patients in two groups. Both groups were checked for metabolic markers and demographic characteristics during admission and before discharge. In the nandrolone group, 25mg of nandrolone (IM) was injected weekly for three weeks. In the control group, normal saline was used as a placebo. To assess metabolic responses, albumin, total protein, and testosterone levels were checked, in addition to static measures such as cross-sections of rectus femur and mid-upper arm circumference. Results: There were no significant differences in SOFA and APACHE 2 scores, PSA, ESR, CRP, and PTC levels between the two groups (p<0.05). Results also showed no significant differences between the mean of length of hospital stay, serum albumin, total protein, hemoglobin, testosterone, and HDL between the two groups (p<0.05). LDL and TG had P-values of 0.01 and 0.012, respectively. MUAC and sonographic findings of rectus femoris muscle were better in the case group (P-values 0.008 and 0.012). Conclusion: Nandrolone had no significant effects on metabolic markers in critically ill patients, except for TG and LDL. The changes in muscle characteristics were significant. However, more study is needed to assess muscular power.
first_indexed 2024-03-12T14:41:54Z
format Article
id doaj.art-476561d285ce478b8aa0f0397c0aab05
institution Directory Open Access Journal
issn 2423-5849
language English
last_indexed 2024-03-12T14:41:54Z
publishDate 2023-06-01
publisher Tehran University of Medical Sciences
record_format Article
series Archives of Anesthesia and Critical Care
spelling doaj.art-476561d285ce478b8aa0f0397c0aab052023-08-16T05:53:20ZengTehran University of Medical SciencesArchives of Anesthesia and Critical Care2423-58492023-06-019310.18502/aacc.v9i3.13116Effects of Nandrolone on Outcomes and Metabolic Response in Critically Ill PatientsHamed Abdollahi0Abolghasem Yousefi1Ladan Ghadami2Department of Anaesthesiology, Amir Alam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.Department of Anaesthesiology, Amir Alam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.Department of Health Care Management ,Amir Alam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. Background: Two major difficulties in critical care are muscle weakness and malnutrition. Their prevalence in critically ill patients is about 30-50% during hospital stays, and they can also affect routine patient life after discharge, even leading to recurrent infection and death. Metabolic responses to injury have specific effects on metabolic phases in patients. Methods: This study is a randomized, double-blind, clinical trial on critically ill patients in two groups. Both groups were checked for metabolic markers and demographic characteristics during admission and before discharge. In the nandrolone group, 25mg of nandrolone (IM) was injected weekly for three weeks. In the control group, normal saline was used as a placebo. To assess metabolic responses, albumin, total protein, and testosterone levels were checked, in addition to static measures such as cross-sections of rectus femur and mid-upper arm circumference. Results: There were no significant differences in SOFA and APACHE 2 scores, PSA, ESR, CRP, and PTC levels between the two groups (p<0.05). Results also showed no significant differences between the mean of length of hospital stay, serum albumin, total protein, hemoglobin, testosterone, and HDL between the two groups (p<0.05). LDL and TG had P-values of 0.01 and 0.012, respectively. MUAC and sonographic findings of rectus femoris muscle were better in the case group (P-values 0.008 and 0.012). Conclusion: Nandrolone had no significant effects on metabolic markers in critically ill patients, except for TG and LDL. The changes in muscle characteristics were significant. However, more study is needed to assess muscular power. https://aacc.tums.ac.ir/index.php/aacc/article/view/617NandroloneIntensive care unit acquired weaknessAnabolismCatabolism
spellingShingle Hamed Abdollahi
Abolghasem Yousefi
Ladan Ghadami
Effects of Nandrolone on Outcomes and Metabolic Response in Critically Ill Patients
Archives of Anesthesia and Critical Care
Nandrolone
Intensive care unit acquired weakness
Anabolism
Catabolism
title Effects of Nandrolone on Outcomes and Metabolic Response in Critically Ill Patients
title_full Effects of Nandrolone on Outcomes and Metabolic Response in Critically Ill Patients
title_fullStr Effects of Nandrolone on Outcomes and Metabolic Response in Critically Ill Patients
title_full_unstemmed Effects of Nandrolone on Outcomes and Metabolic Response in Critically Ill Patients
title_short Effects of Nandrolone on Outcomes and Metabolic Response in Critically Ill Patients
title_sort effects of nandrolone on outcomes and metabolic response in critically ill patients
topic Nandrolone
Intensive care unit acquired weakness
Anabolism
Catabolism
url https://aacc.tums.ac.ir/index.php/aacc/article/view/617
work_keys_str_mv AT hamedabdollahi effectsofnandroloneonoutcomesandmetabolicresponseincriticallyillpatients
AT abolghasemyousefi effectsofnandroloneonoutcomesandmetabolicresponseincriticallyillpatients
AT ladanghadami effectsofnandroloneonoutcomesandmetabolicresponseincriticallyillpatients